500O Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study Article Swipe
María Vieito
,
Juan Manuel Sepúlveda-Sánchez
,
Víctor Moreno
,
Giuseppe Lombardi
,
Agostina Stradella
,
Rikke Hedegaard Dahlrot
,
Charlotte Aaquist Haslund
,
Marjolein Geurts
,
Estela Pineda
,
Petter Brandal
,
Filip De Vos
,
María Ángeles Vaz Salgado
,
Maria Martinez‐García
,
Marina Macchini
,
Barbara Amoroso
,
Teresa Sánchez
,
Bishoy Hanna
,
X. Li
,
Zariana Nikolova
,
Matteo Simonelli
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.annonc.2023.09.1694
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.annonc.2023.09.1694
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.annonc.2023.09.1694
- http://www.annalsofoncology.org/article/S0923753423025310/pdf
- OA Status
- bronze
- Cited By
- 2
- References
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4387811747
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4387811747Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.annonc.2023.09.1694Digital Object Identifier
- Title
-
500O Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-10-01Full publication date if available
- Authors
-
María Vieito, Juan Manuel Sepúlveda-Sánchez, Víctor Moreno, Giuseppe Lombardi, Agostina Stradella, Rikke Hedegaard Dahlrot, Charlotte Aaquist Haslund, Marjolein Geurts, Estela Pineda, Petter Brandal, Filip De Vos, María Ángeles Vaz Salgado, Maria Martinez‐García, Marina Macchini, Barbara Amoroso, Teresa Sánchez, Bishoy Hanna, X. Li, Zariana Nikolova, Matteo SimonelliList of authors in order
- Landing page
-
https://doi.org/10.1016/j.annonc.2023.09.1694Publisher landing page
- PDF URL
-
https://www.annalsofoncology.org/article/S0923753423025310/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.annalsofoncology.org/article/S0923753423025310/pdfDirect OA link when available
- Concepts
-
Medicine, Adverse effect, Internal medicine, Rash, Discontinuation, Concomitant, Clinical endpoint, Nausea, Gastroenterology, Temozolomide, Surgery, Radiation therapy, Clinical trialTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 2Per-year citation counts (last 5 years)
- References (count)
-
1Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4387811747 |
|---|---|
| doi | https://doi.org/10.1016/j.annonc.2023.09.1694 |
| ids.doi | https://doi.org/10.1016/j.annonc.2023.09.1694 |
| ids.openalex | https://openalex.org/W4387811747 |
| fwci | 0.67474997 |
| type | article |
| title | 500O Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study |
| biblio.issue | |
| biblio.volume | 34 |
| biblio.last_page | S392 |
| biblio.first_page | S392 |
| grants[0].funder | https://openalex.org/F4320307115 |
| grants[0].award_id | |
| grants[0].funder_display_name | Bristol-Myers Squibb |
| topics[0].id | https://openalex.org/T12829 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9934999942779541 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Advanced Breast Cancer Therapies |
| topics[1].id | https://openalex.org/T11752 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.991100013256073 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Treatment and Pharmacology |
| topics[2].id | https://openalex.org/T10129 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9884999990463257 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2716 |
| topics[2].subfield.display_name | Genetics |
| topics[2].display_name | Glioma Diagnosis and Treatment |
| funders[0].id | https://openalex.org/F4320307115 |
| funders[0].ror | https://ror.org/00gtmwv55 |
| funders[0].display_name | Bristol-Myers Squibb |
| is_xpac | False |
| apc_list.value | 4060 |
| apc_list.currency | USD |
| apc_list.value_usd | 4060 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9432986974716187 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C197934379 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7173236608505249 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[1].display_name | Adverse effect |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.6819886565208435 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C2778570526 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5513566732406616 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q653197 |
| concepts[3].display_name | Rash |
| concepts[4].id | https://openalex.org/C2778715236 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5198143720626831 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q55622662 |
| concepts[4].display_name | Discontinuation |
| concepts[5].id | https://openalex.org/C2779384505 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4856380522251129 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q17007513 |
| concepts[5].display_name | Concomitant |
| concepts[6].id | https://openalex.org/C203092338 |
| concepts[6].level | 3 |
| concepts[6].score | 0.48240387439727783 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1340863 |
| concepts[6].display_name | Clinical endpoint |
| concepts[7].id | https://openalex.org/C2780580376 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4562259316444397 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q186889 |
| concepts[7].display_name | Nausea |
| concepts[8].id | https://openalex.org/C90924648 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4547504782676697 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[8].display_name | Gastroenterology |
| concepts[9].id | https://openalex.org/C2777389519 |
| concepts[9].level | 3 |
| concepts[9].score | 0.41047078371047974 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q425088 |
| concepts[9].display_name | Temozolomide |
| concepts[10].id | https://openalex.org/C141071460 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3984636068344116 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[10].display_name | Surgery |
| concepts[11].id | https://openalex.org/C509974204 |
| concepts[11].level | 2 |
| concepts[11].score | 0.21270054578781128 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q180507 |
| concepts[11].display_name | Radiation therapy |
| concepts[12].id | https://openalex.org/C535046627 |
| concepts[12].level | 2 |
| concepts[12].score | 0.19443708658218384 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[12].display_name | Clinical trial |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9432986974716187 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/adverse-effect |
| keywords[1].score | 0.7173236608505249 |
| keywords[1].display_name | Adverse effect |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.6819886565208435 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/rash |
| keywords[3].score | 0.5513566732406616 |
| keywords[3].display_name | Rash |
| keywords[4].id | https://openalex.org/keywords/discontinuation |
| keywords[4].score | 0.5198143720626831 |
| keywords[4].display_name | Discontinuation |
| keywords[5].id | https://openalex.org/keywords/concomitant |
| keywords[5].score | 0.4856380522251129 |
| keywords[5].display_name | Concomitant |
| keywords[6].id | https://openalex.org/keywords/clinical-endpoint |
| keywords[6].score | 0.48240387439727783 |
| keywords[6].display_name | Clinical endpoint |
| keywords[7].id | https://openalex.org/keywords/nausea |
| keywords[7].score | 0.4562259316444397 |
| keywords[7].display_name | Nausea |
| keywords[8].id | https://openalex.org/keywords/gastroenterology |
| keywords[8].score | 0.4547504782676697 |
| keywords[8].display_name | Gastroenterology |
| keywords[9].id | https://openalex.org/keywords/temozolomide |
| keywords[9].score | 0.41047078371047974 |
| keywords[9].display_name | Temozolomide |
| keywords[10].id | https://openalex.org/keywords/surgery |
| keywords[10].score | 0.3984636068344116 |
| keywords[10].display_name | Surgery |
| keywords[11].id | https://openalex.org/keywords/radiation-therapy |
| keywords[11].score | 0.21270054578781128 |
| keywords[11].display_name | Radiation therapy |
| keywords[12].id | https://openalex.org/keywords/clinical-trial |
| keywords[12].score | 0.19443708658218384 |
| keywords[12].display_name | Clinical trial |
| language | en |
| locations[0].id | doi:10.1016/j.annonc.2023.09.1694 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S41454044 |
| locations[0].source.issn | 0923-7534, 1569-8041 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0923-7534 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Annals of Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | http://www.annalsofoncology.org/article/S0923753423025310/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Annals of Oncology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.annonc.2023.09.1694 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5004217317 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7531-343X |
| authorships[0].author.display_name | María Vieito |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210127641, https://openalex.org/I4387155398 |
| authorships[0].affiliations[0].raw_affiliation_string | Medical Oncology Dept., Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| authorships[0].institutions[0].id | https://openalex.org/I4387155398 |
| authorships[0].institutions[0].ror | https://ror.org/054xx3904 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4387153040, https://openalex.org/I4387155398 |
| authorships[0].institutions[0].country_code | |
| authorships[0].institutions[0].display_name | Vall d'Hebron Institute of Oncology |
| authorships[0].institutions[1].id | https://openalex.org/I4210127641 |
| authorships[0].institutions[1].ror | https://ror.org/03ba28x55 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210127641 |
| authorships[0].institutions[1].country_code | ES |
| authorships[0].institutions[1].display_name | Vall d'Hebron Hospital Universitari |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | M. Vieito Villar |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Medical Oncology Dept., Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| authorships[1].author.id | https://openalex.org/A5080323920 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3548-9961 |
| authorships[1].author.display_name | Juan Manuel Sepúlveda-Sánchez |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210101691 |
| authorships[1].affiliations[0].raw_affiliation_string | Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain |
| authorships[1].institutions[0].id | https://openalex.org/I4210101691 |
| authorships[1].institutions[0].ror | https://ror.org/00qyh5r35 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210101691, https://openalex.org/I4210139293 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Hospital Universitario 12 De Octubre |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | J.M. Sepúlveda Sánchez |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain |
| authorships[2].author.id | https://openalex.org/A5006299989 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6099-4236 |
| authorships[2].author.display_name | Víctor Moreno |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210129357 |
| authorships[2].affiliations[0].raw_affiliation_string | START Madrid-FJD, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I4210129357 |
| authorships[2].institutions[0].ror | https://ror.org/049nvyb15 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210129357 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Hospital Universitario Fundación Jiménez Díaz |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | V. Moreno Garcia |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | START Madrid-FJD, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain |
| authorships[3].author.id | https://openalex.org/A5062223253 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1316-2132 |
| authorships[3].author.display_name | Giuseppe Lombardi |
| authorships[3].countries | IT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210109345 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Oncology, Istituto Oncologico Veneto, Oncologia 1, IOV-IRCCS, Padua, Italy |
| authorships[3].institutions[0].id | https://openalex.org/I4210109345 |
| authorships[3].institutions[0].ror | https://ror.org/01xcjmy57 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[3].institutions[0].country_code | IT |
| authorships[3].institutions[0].display_name | Istituto Oncologico Veneto |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | G. Lombardi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Oncology, Istituto Oncologico Veneto, Oncologia 1, IOV-IRCCS, Padua, Italy |
| authorships[4].author.id | https://openalex.org/A5062510457 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2307-8869 |
| authorships[4].author.display_name | Agostina Stradella |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[4].affiliations[0].raw_affiliation_string | Medical Oncology Department, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain |
| authorships[4].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[4].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | A. Stradella |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Medical Oncology Department, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain |
| authorships[5].author.id | https://openalex.org/A5073102947 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1538-4361 |
| authorships[5].author.display_name | Rikke Hedegaard Dahlrot |
| authorships[5].countries | DK |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2801498763 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Oncology, Odense University Hospital, Odense, Denmark |
| authorships[5].institutions[0].id | https://openalex.org/I2801498763 |
| authorships[5].institutions[0].ror | https://ror.org/00ey0ed83 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2801498763 |
| authorships[5].institutions[0].country_code | DK |
| authorships[5].institutions[0].display_name | Odense University Hospital |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | R.H. Dahlrot |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Oncology, Odense University Hospital, Odense, Denmark |
| authorships[6].author.id | https://openalex.org/A5038925165 |
| authorships[6].author.orcid | https://orcid.org/0009-0004-6571-2196 |
| authorships[6].author.display_name | Charlotte Aaquist Haslund |
| authorships[6].countries | DK |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2799976261 |
| authorships[6].affiliations[0].raw_affiliation_string | Oncology Department and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark |
| authorships[6].institutions[0].id | https://openalex.org/I2799976261 |
| authorships[6].institutions[0].ror | https://ror.org/02jk5qe80 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2799976261 |
| authorships[6].institutions[0].country_code | DK |
| authorships[6].institutions[0].display_name | Aalborg University Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | C.A. Haslund |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Oncology Department and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark |
| authorships[7].author.id | https://openalex.org/A5091396880 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2369-0035 |
| authorships[7].author.display_name | Marjolein Geurts |
| authorships[7].countries | NL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210149908 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, Netherlands |
| authorships[7].institutions[0].id | https://openalex.org/I4210149908 |
| authorships[7].institutions[0].ror | https://ror.org/03r4m3349 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I2801952686, https://openalex.org/I4210149908 |
| authorships[7].institutions[0].country_code | NL |
| authorships[7].institutions[0].display_name | Erasmus MC Cancer Institute |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | M. Geurts |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, Netherlands |
| authorships[8].author.id | https://openalex.org/A5112662696 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Estela Pineda |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[8].affiliations[0].raw_affiliation_string | Medical Oncology Department, Hospital Clínic de Barcelona, Barcelona, Spain |
| authorships[8].institutions[0].id | https://openalex.org/I4210115097 |
| authorships[8].institutions[0].ror | https://ror.org/02a2kzf50 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210115097 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Hospital Clínic de Barcelona |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | E. Pineda |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Medical Oncology Department, Hospital Clínic de Barcelona, Barcelona, Spain |
| authorships[9].author.id | https://openalex.org/A5029756439 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-0259-495X |
| authorships[9].author.display_name | Petter Brandal |
| authorships[9].countries | NO |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1281400175 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Oncology, Oslo University Hospital, Oslo, Norway |
| authorships[9].institutions[0].id | https://openalex.org/I1281400175 |
| authorships[9].institutions[0].ror | https://ror.org/00j9c2840 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I1281400175 |
| authorships[9].institutions[0].country_code | NO |
| authorships[9].institutions[0].display_name | Oslo University Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | P. Brandal |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Oncology, Oslo University Hospital, Oslo, Norway |
| authorships[10].author.id | https://openalex.org/A5029982164 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-9082-5991 |
| authorships[10].author.display_name | Filip De Vos |
| authorships[10].countries | NL |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I3018483916 |
| authorships[10].affiliations[0].raw_affiliation_string | Medical Oncology Department, University Medical Center Utrecht, Utrecht, Netherlands |
| authorships[10].institutions[0].id | https://openalex.org/I3018483916 |
| authorships[10].institutions[0].ror | https://ror.org/0575yy874 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I3018483916 |
| authorships[10].institutions[0].country_code | NL |
| authorships[10].institutions[0].display_name | University Medical Center Utrecht |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | F.Y.F.L. De Vos |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Medical Oncology Department, University Medical Center Utrecht, Utrecht, Netherlands |
| authorships[11].author.id | https://openalex.org/A5101734070 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-5913-9002 |
| authorships[11].author.display_name | María Ángeles Vaz Salgado |
| authorships[11].countries | ES |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210161852 |
| authorships[11].affiliations[0].raw_affiliation_string | Medical Oncology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain |
| authorships[11].institutions[0].id | https://openalex.org/I4210161852 |
| authorships[11].institutions[0].ror | https://ror.org/050eq1942 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210139293, https://openalex.org/I4210161852 |
| authorships[11].institutions[0].country_code | ES |
| authorships[11].institutions[0].display_name | Hospital Universitario Ramón y Cajal |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | M.A. Vaz Salgado |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Medical Oncology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain |
| authorships[12].author.id | https://openalex.org/A5037165485 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5891-3935 |
| authorships[12].author.display_name | Maria Martinez‐García |
| authorships[12].countries | ES |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210130874 |
| authorships[12].affiliations[0].raw_affiliation_string | Medical Oncology Department, Hospital del Mar, Barcelona, Spain |
| authorships[12].institutions[0].id | https://openalex.org/I4210130874 |
| authorships[12].institutions[0].ror | https://ror.org/03a8gac78 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210130874 |
| authorships[12].institutions[0].country_code | ES |
| authorships[12].institutions[0].display_name | Hospital Del Mar |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | M. Martinez Garcia |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Medical Oncology Department, Hospital del Mar, Barcelona, Spain |
| authorships[13].author.id | https://openalex.org/A5085754158 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-5395-0155 |
| authorships[13].author.display_name | Marina Macchini |
| authorships[13].countries | IT |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I154387261, https://openalex.org/I4210153126, https://openalex.org/I4387155925 |
| authorships[13].affiliations[0].raw_affiliation_string | Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy |
| authorships[13].institutions[0].id | https://openalex.org/I4387155925 |
| authorships[13].institutions[0].ror | https://ror.org/006x48140 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210153126, https://openalex.org/I4387155925 |
| authorships[13].institutions[0].country_code | |
| authorships[13].institutions[0].display_name | Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele |
| authorships[13].institutions[1].id | https://openalex.org/I4210153126 |
| authorships[13].institutions[1].ror | https://ror.org/04tfzc498 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I4210153126 |
| authorships[13].institutions[1].country_code | IT |
| authorships[13].institutions[1].display_name | Istituti di Ricovero e Cura a Carattere Scientifico |
| authorships[13].institutions[2].id | https://openalex.org/I154387261 |
| authorships[13].institutions[2].ror | https://ror.org/01gmqr298 |
| authorships[13].institutions[2].type | education |
| authorships[13].institutions[2].lineage | https://openalex.org/I154387261 |
| authorships[13].institutions[2].country_code | IT |
| authorships[13].institutions[2].display_name | Vita-Salute San Raffaele University |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | M. Macchini |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy |
| authorships[14].author.id | https://openalex.org/A5009835097 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Barbara Amoroso |
| authorships[14].affiliations[0].raw_affiliation_string | Early Clinical Development, Centre for Innovation and Translational Research Europe, a Bristol Myers Squibb Company, Seville, Spain |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | B. Amoroso |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Early Clinical Development, Centre for Innovation and Translational Research Europe, a Bristol Myers Squibb Company, Seville, Spain |
| authorships[15].author.id | https://openalex.org/A5035231990 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-2711-7423 |
| authorships[15].author.display_name | Teresa Sánchez |
| authorships[15].affiliations[0].raw_affiliation_string | Early Clinical Development, Centre for Innovation and Translational Research Europe, a Bristol Myers Squibb Company, Seville, Spain |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | T. Sanchez |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Early Clinical Development, Centre for Innovation and Translational Research Europe, a Bristol Myers Squibb Company, Seville, Spain |
| authorships[16].author.id | https://openalex.org/A5001006273 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-7027-6553 |
| authorships[16].author.display_name | Bishoy Hanna |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210091812 |
| authorships[16].affiliations[0].raw_affiliation_string | Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA |
| authorships[16].institutions[0].id | https://openalex.org/I4210091812 |
| authorships[16].institutions[0].ror | https://ror.org/00gtmwv55 |
| authorships[16].institutions[0].type | company |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210091812 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Bristol-Myers Squibb (United States) |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | B. Hanna |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA |
| authorships[17].author.id | https://openalex.org/A5064526855 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | X. Li |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210091812 |
| authorships[17].affiliations[0].raw_affiliation_string | Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA |
| authorships[17].institutions[0].id | https://openalex.org/I4210091812 |
| authorships[17].institutions[0].ror | https://ror.org/00gtmwv55 |
| authorships[17].institutions[0].type | company |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210091812 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Bristol-Myers Squibb (United States) |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | X. Li |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA |
| authorships[18].author.id | https://openalex.org/A5085981984 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-5315-4463 |
| authorships[18].author.display_name | Zariana Nikolova |
| authorships[18].affiliations[0].raw_affiliation_string | Early Clinical Development, Centre for Innovation and Translational Research Europe, a Bristol Myers Squibb Company, Seville, Spain |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Z. Nikolova |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Early Clinical Development, Centre for Innovation and Translational Research Europe, a Bristol Myers Squibb Company, Seville, Spain |
| authorships[19].author.id | https://openalex.org/A5021465650 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-5264-1251 |
| authorships[19].author.display_name | Matteo Simonelli |
| authorships[19].countries | IT |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I1339471597, https://openalex.org/I4210163047 |
| authorships[19].affiliations[0].raw_affiliation_string | Oncology and Hematology Department, IRCCS Humanitas Research Hospital and Department of Biomedical Sciences, Humanitas University, Milan, Italy |
| authorships[19].institutions[0].id | https://openalex.org/I1339471597 |
| authorships[19].institutions[0].ror | https://ror.org/020dggs04 |
| authorships[19].institutions[0].type | education |
| authorships[19].institutions[0].lineage | https://openalex.org/I1339471597 |
| authorships[19].institutions[0].country_code | IT |
| authorships[19].institutions[0].display_name | Humanitas University |
| authorships[19].institutions[1].id | https://openalex.org/I4210163047 |
| authorships[19].institutions[1].ror | https://ror.org/05d538656 |
| authorships[19].institutions[1].type | healthcare |
| authorships[19].institutions[1].lineage | https://openalex.org/I4210153126, https://openalex.org/I4210163047 |
| authorships[19].institutions[1].country_code | IT |
| authorships[19].institutions[1].display_name | IRCCS Humanitas Research Hospital |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | M. Simonelli |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Oncology and Hematology Department, IRCCS Humanitas Research Hospital and Department of Biomedical Sciences, Humanitas University, Milan, Italy |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.annalsofoncology.org/article/S0923753423025310/pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 500O Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12829 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9934999942779541 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Advanced Breast Cancer Therapies |
| related_works | https://openalex.org/W2235074116, https://openalex.org/W2022503084, https://openalex.org/W2019927904, https://openalex.org/W2182202988, https://openalex.org/W2899766789, https://openalex.org/W145662657, https://openalex.org/W4389442266, https://openalex.org/W2042969729, https://openalex.org/W4248982232, https://openalex.org/W3112002494 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/j.annonc.2023.09.1694 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S41454044 |
| best_oa_location.source.issn | 0923-7534, 1569-8041 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0923-7534 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Annals of Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | http://www.annalsofoncology.org/article/S0923753423025310/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Annals of Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.annonc.2023.09.1694 |
| primary_location.id | doi:10.1016/j.annonc.2023.09.1694 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S41454044 |
| primary_location.source.issn | 0923-7534, 1569-8041 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0923-7534 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Annals of Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | http://www.annalsofoncology.org/article/S0923753423025310/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Annals of Oncology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.annonc.2023.09.1694 |
| publication_date | 2023-10-01 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W4387811747 |
| referenced_works_count | 1 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 6 |
| institutions_distinct_count | 20 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.74236164 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |